Illumina Faces $1.89 Billion Blow After Grail Spinoff, Regulatory Challenges
Illumina, the leading name in sequencing technology, is bracing for a hefty financial blow following its spinoff of cancer testing […]
Illumina, the leading name in sequencing technology, is bracing for a hefty financial blow following its spinoff of cancer testing […]
In a setback for Rocket Pharmaceuticals, the FDA has issued a Complete Response Letter rejecting its gene therapy, Kresladi, designed
The Subject Expert Committee (SEC), an advisory body to India’s national drug regulator, has recommended granting permission for the import
The Tamil Nadu Pharma Traders’ Association (TNPTA) has raised concerns over the promotional strategies of MedPlus, a prominent chain pharmacy
Researchers at the Department of Bioengineering (BE) at the Indian Institute of Science (IISc) have developed a promising 3D hydrogel
The Department of Pharmaceuticals (DoP) has given the green light for Rs. 243 crore in funding to establish Centers of
In a significant development for India’s pharmaceutical sector, small and medium enterprises (MSMEs) are poised for a major makeover under
Genmab A/S, a global biotechnology company focused on advancing patient care, has received positive news from the European Medicines Agency’s
The National Institutes of Health (NIH) is embarking on a groundbreaking clinical trial to assess the safety and effectiveness of
Roche has received positive news from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), which has